News + Filings Transactions Holdings
|
Flagship Pioneering Inc.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/27/2023 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 2M | $5.78 | $11.5M | By Flagship Pioneering Special Opportunities Fund II, L.P. | 02/27/2023 |
| 02/27/2023 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 1.3M | $5.78 | $7.7M | By Flagship Pioneering Fund VII, L.P. | 02/27/2023 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 1.1M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 5.9M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 8.4M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 220.6k | $17.00 | $3.7M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 970.6k | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 661.8k | $17.00 | $11.2M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 1.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 294.1k | $17.00 | $5M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 4.1M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 22.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 27.4M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 2.7M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 666.7k | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 13.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 3.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 1.7M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 5M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 1.1M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 5.9M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 8.4M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 220.6k | $17.00 | $3.7M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 970.6k | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 661.8k | $17.00 | $11.2M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 1.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 294.1k | $17.00 | $5M | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 4.1M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 22.3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 27.4M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series A Convertible Preferred Stock | 3M | $0.00 | $0 | See Footnotes | 08/03/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 2.7M | $0.00 | $0 | See Footnotes | 08/03/2021 |
|
|